Weekly Psychedelic Links - December 2022

12.2.22

Cannabis

• Biden Signs Marijuana Research Bill, A Historic First For Federal Cannabis Reform (Marijuana Moment)

• Idaho Plans for Medical Cannabis Legalization on the Ballot in 2024 (High Times)

• Ohio Senate Votes To Remove Marijuana Paraphernalia Convictions From Criminal Records And Allow Broader Expungement (Marijuana Moment)

• Police in India Say Rats Ate More Than 1,100 Pounds of Confiscated Weed (High Times)

• Young Americans Are Twice As Likely To Smoke Marijuana Than Cigarettes, New Gallup Data Shows (Marijuana Moment)

• New Federal Job Applications Won’t Ask About Most Marijuana Use Unless It Was Within The Past 90 Days (Marijuana Moment)

• Many People with Bipolar Disorder Use Cannabis. It May Sometimes Help (Scientific American)

• University Researchers Exploring Cannabis As A Treatment For Covid-19 (Forbes)

• New York’s illicit weed products are weak and full of toxins, study finds (Leafly)

• Medical Marijuana Legalization Linked To Reduced Opioid Use By Cancer Patients, American Medical Association Study Finds (Marijuana Moment)

• Pennsylvania Starts Program Providing Financial Assistance to Low-Income Cannabis Patients (High Times)

• Wedding Guest Files Lawsuit Over Pot-Infused Reception Food (High Times)

• These States Almost Legalized Marijuana In 2022 (Marijuana Moment)

LSD

• Many Trips, Diminishing Returns: Cross-Tolerance Between LSD and DOI (Psychedelic Science Review)

• Former CEO Sues Company That Fired Him for Microdosing LSD in an Investor Meeting (Futurism)

Magic Mushrooms

• DEA Proposes Even Higher 2023 Production Quotas For Psychedelics Like MDMA And Psilocyn (Marijuana Moment)

• Non-profit Organization Marches on Canadian Capital To Fight for Therapeutic Mushrooms (High Times)

MDMA

• The man who took 40,000 ecstasy pills (The Face)

• Climate Lessons from Cambodia’s Illegal MDMA Market (TalkingDrugs)

Ayahuasca

• Why Ayahuasca Is Miley Cyrus' 'Favorite' Drug (And How It Supported Her Veganism) (Benzinga)

• After closing its doors in Canterbury, a church serving hallucinogenic tea vows to reopen elsewhere (NHPR)

• Ceremonial Ayahuasca in Amazonian Retreats: Mental Health and Epigenetic Outcomes From a Six-Month Naturalistic Study (Chacruna)

Synthetic Cannabinoids

• Prison “K2”: The Hidden Center of a Chaotic New Drug War (Filter)

Ketamine

• Laid-off workers can now get a free month of ketamine-assisted therapy services to help with their mental health (Fortune)

• Low-dose ketamine may reduce shivering following spinal anesthesia (Physicians Weekly)

• Ketamine for Depression Poses “Significant Risk to the Public” (Mad in America)

• Study shows how ketamine administration starkly changes neuronal activity patterns in the brain (News-Medical.net)

Miscellaneous

• Berkeley, California Officials Approve Psychedelics Decriminalization Resolution Amid Pushback From Reform Advocates (Marijuana Moment)

• Colombian And Mexican Presidents Announce International Effort To Reshape Drug Policy, Condemning ‘Failure’ Of Prohibition (Marijuana Moment)

• Colorado Governor To Appoint Psychedelics Advisory Panel After Voters Approve Legalization Ballot Measure (Marijuana Moment)

• Why the “Psychedelic Renaissance” is just Colonialism by Another Name (DoubleBlind)

• Could the Latest Science on Psychedelics Revolutionise the Way We Understand Our Minds? (Men's Health)

12.9.22

Cannabis

• Brittney Griner released from Russian detention in prisoner swap (Leafly)

• Legalization Amendment To Be Added to Missouri Constitution (High Times)

• New Jersey Marijuana Regulators Approve Rules For Public Cannabis Consumption Areas (Marijuana Moment)

• Colombian Senate Approves Marijuana Legalization Bill, Bringing Country Closer To Ending Prohibition (Marijuana Moment)

• Study: Cannabis Has ‘Uniquely Beneficial Effects’ on People With Bipolar Disorder (High Times)

• Pain relief from marijuana comes from a belief it helps, study finds (CNN)

• Delivery is in the works for New York’s new legal weed stores (Leafly)

• Children are ditching alcohol for marijuana, as 20-year national US study shows a 245% increase (EurekAlert!)

• Oregon recalls thousands of cannabis products over pesticide concerns (Marijuana Business Daily)

• Minnesota Files Lawsuit Against Several Companies for Illicit Edible Sales (High Times)

• As Congress Stalls On Marijuana Banking, New Report Details Public Safety Risk Of Cash-Intensive Dispensaries (Marijuana Moment)

• NORML Report Highlights Citywide Policies Depenalizing Marijuana Law Enforcement (NORML)

• Study: ‘Significant’ negative association between medical cannabis sales, alcohol (Marijuana Business Daily)

• Dispensaries’ Cashless ATM Transactions Get The Ax (High Times)

• Connecticut: Governor Announces Intent to Expunge 40,000+ Marijuana-Related Convictions (NORML)

• Biden’s Health Secretary Shares Marijuana Scheduling News At 4:20—Again (Marijuana Moment)

• Marijuana packaging rebrands can draw consumers, create cohesion, reflect values (Marijuana Business Daily)

• Trend Sees Brands Pairing Top-Shelf Weed, Fine Dining (High Times)

LSD

• Study on LSD microdosing uncovers neuropsychological mechanisms that could underlie anti-depressant effects (PsyPost)

Magic Mushrooms

• Portlanders Explain Why They’re Waiting in Line for Psychedelic Mushrooms (Willamette Week)

• Study suggests psilocybin increases mindfulness, especially when accompanied by mystical experiences (PsyPost)

• Amsterdam’s Last Shroom Lounge (DoubleBlind)

• Diamond Therapeutics completes Phase I clinical study of low-dose psilocybin in healthy human subjects (PR Newswire)

• Oregon store allegedly selling psychedelic mushrooms raided (The Seattle Times)

MDMA

• MDMA may be available for medical treatment "as soon as 2024" in US hospitals (Mixmag)

• Wastewater data shows 286% increase in ecstasy use during pandemic (Healio)

• Abuse Potential: Considerations for Rescheduling MDMA and Psychedelics (Psychedelic Science Review)

DMT

• The Gestures of DMT Jesters (Sam Woolfe)

Ayahuasca

• A Canadian psychedelic drug company has created medical grade ayahuasca (Toronto Star)

• Modulatory Effects of Ayahuasca on Personality Structure in a Traditional Framework (Chacruna)

• Declaration of The 4th Brazilian Indigenous Ayahuasca Conference (Chacruna)

Ketamine

• Now Companies Can Buy Insurance To Cover Ketamine Therapy for Employees (Lucid News)

• Using Ketamine to Treat Anorexia (Psychology Today)

• Meta-Analysis of Intravenous vs Intranasal Ketamine (Psychiatric Times)

• Low-dose Ketamine Effective In Reducing The Incidence Of Shivering Following Spinal Anesthesia (Medical Dialogues)

Miscellaneous

• MAPS Found Liable in Wrongful Death Lawsuit (Lucid News)

• Most States Will Legalize Psychedelics By 2037, Analysis Published By American Medical Association Predicts (Marijuana Moment)

• When virtual reality meets psychedelic therapy (Mashable)

• How Will Our Value Systems Affect The Psychedelic Movement? (Maps of the Mind)

• We’re rushing the use of psychedelics as medicine, researchers say (New Scientist)

• Awakn Makes Its Case To Investors (Lucid News)

• Punk Ethos & Psychedelic Practice (Maps of the Mind)

12.16.22

Cannabis

• Recreational Weed Now Legal in Missouri (High Times)

• Connecticut: Adult-Use Cannabis Sales to Begin Next Month (NORML)

• New Hampshire GOP And Democratic House Leaders Team Up On Marijuana Legalization Bill For 2023 (Marijuana Moment)

• Here’s how New York’s legal weed delivery will work (Leafly)

• Teen Marijuana Use Remained Stable In 2022, Despite More States Legalizing And Lifting Of Pandemic Restrictions (Marijuana Moment)

• Kansas City: Officials Dismiss Hundreds of Marijuana Cases Following Statewide Legalization Vote (NORML)

• Kansas Lawmakers Plan To Introduce Medical Cannabis Legalization Bill (High Times)

• Prosecution collapses against execs caught up in CannTrust cannabis scandal (CBC)

• Texas Activists Turn In Signatures To Put Marijuana Decriminalization Back In Voters’ Hands After City Council Repeal (Marijuana Moment)

• Massachusetts To Add Lessons on Weed Impairment to Driver’s Ed (High Times)

• Nearly 2 Million Marijuana Convictions Have Been Pardoned Or Expunged In The U.S. In The Past Five Years, New Report Shows (Marijuana Moment)

• Australian Residents Could Save $850 Million Annually if Cannabis is Decriminalized (High Times)

• Marijuana Legalization Reduces Arrests Even In States That Already Decriminalized, American Medical Association Study Finds (Marijuana Moment)

LSD

• Up to 9% of LSD and psilocybin users report reoccurring effects after drug has worn off (PsyPost)

• Gut Feeling: Links Between LSD, Endocannabinoids, and the Microbiome (Psychedelic Science Review)

Magic Mushrooms

• Florida halts amanita muscaria sales at nation’s only brick-and-mortar retailer (Leafly)

• COMP360 psilocybin therapy shows potential in open-label study in type II bipolar disorder presented at ACNP (Psychedelic Alpha)

• Here’s why police are raiding psychedelic mushroom stores in major cities (Leafly)

• Rat Study Examines Psilocybin as Treatment for Autism Spectrum Disorder (High Times)

MDMA

• The History and Benefits of MDMA, the New Tool in Mental Health Again (Daily Kos)

DMT

• Experiencing a Changa Ceremony at an Oakland Plant Medicine Church (Lucid News)

Ayahuasca

• Aaron Rodgers says doing psychedelic drug ayahuasca helped him overcome his ‘fear of death’ (The Independent)

5-MeO-DMT

• UCL To Lead First-Ever Brain Imaging Study Among Psychedelic Retreat Participants (High Times)

• PsyBio Therapeutics Takes Initial Step to Help Protect the Sonoran Desert Toad as it Files Three New Provisional Patent Applications, Including Intellectual Property Protection for the Biosynthetic Production of 5-MeO-DMT (Psychedelic Alpha)

Peyote

• Inside the battle to save the sacred peyote ceremony: ‘We’re in dire straits’ (The Guardian)

Novel Psychoactive Substances

• Israeli Based Biotech Company Clearmind Completes IND-Enabling Studies for CMND-100 (Psychedelic Alpha)

Ketamine

• Ketamine plus therapy could help treat alcoholism, say researchers (The Guardian)

Miscellaneous

• Verdict in Lawsuit Assigns MAPS 25% Liability and $1M in Damages (Lucid News)

• New center takes multidisciplinary approach to the study of psychedelics (University of Michigan)

• It’s Not Just About Pot. Our Entire Drug Policy Needs an Overhaul. (The New York Times)

• The Effects of Sleep Deprivation on a Psychedelic Experience (Sam Woolfe)

• Would You Be Friends With Your Friends if You Didn’t Do Drugs Together? (VICE)

• Why is Gender-Affirming Care Needed in the Psychedelic Space? (Chacruna)

• How Many Likes Does it Take to be a Psychedelic Thought Leader? (Lucid News)

12.23.22

Cannabis

• First words from Brittney Griner: Thanks Biden, vows to help free others (Leafly)

• Federally Funded Study Finds Teen Use Rates Largely Unchanged by Legalization (NORML)

• Canada Destroys a Record Amount of Cannabis (High Times)

• District of Columbia: Council Members Advance Legislation to Expunge Tens of Thousands of Marijuana Convictions (NORML)

• Afroman Announces 2024 Run for President (High Times)

• Twitter Stops Suggesting People Who Search For ‘Marijuana’ May Need Drug Treatment (Marijuana Moment)

• Canada’s Cannabis Legalization Is Working Effectively, Annual Survey Suggests (Forbes)

• New Washington Bill Would Allow Interstate Marijuana Commerce (Marijuana Moment)

• New Report Analyzes Medical Pot Patients’ Consumption Habits (High Times)

• Majority Of Texas Voters Back Marijuana Legalization, And Three In Four Support Decriminalization, Poll Finds (Marijuana Moment)

LSD

• How LSD evolved from CIA mind-control drug to counterculture emblem (Leafly)

Magic Mushrooms

• Quebec covers psilocybin therapy under medical insurance in historic first (Leafly)

• Oregon Psilocybin Entrepreneurs Navigate Business Requirements (Lucid News)

Ayahuasca

• Canadian Company Announces Ayahuasca Pills (Chacruna)

• Music and ayahuasca’s role in treating substance use disorders in men (UC Riverside)

Datura

• Weed responsible for hallucinogenic spinach recall identified as thornapple (The Guardian)

Miscellaneous

• New Bill Tries to Decriminalize Psychedelics in California—Again (DoubleBlind)

• The Myth of the Psychedelic Santa (Lucid News)

• U.K. Police Chiefs Call for Decriminalization of First-Time Drug Offenses (High Times)

• Israel-Based Clearmind Medicine Granted U.S. Patent for Psychedelic-Based Alcohol Substitute (Psychedelic Alpha)

• Placebo Problems: Boundary Works in the Psychedelic Science Renaissance (Chacruna)

12.30.22

Cannabis

• Record Number of Scientific Papers Published About Cannabis in 2022 (NORML)

• Washington, D.C. Passes Bill To Expand Medical Weed Sales (High Times)

• Google Ends Ban On Advertising Certain Hemp And CBD Products In Parts Of U.S. (Marijuana Moment)

• Clinical Trial Finds Cannabis Oil is Well-Tolerated, Effective Insomnia Treatment (High Times)

• Snoop Dogg’s Death Row Records To Launch Its Own Cannabis Brand (Forbes)

• California Gov. Gavin Newsom Pardons 10, Some Cannabis Convictions (High Times)

• A dying US cancer patient used cannabis to ease pain. His hospital called the police (The Guardian)

• South Dakota Activists File Measure That Could Put Marijuana Legalization On Ballot For Third Election In A Row (Marijuana Moment)

• Is legal weed doomed to be run by big business? (Vox)

• Texas Marijuana Activists Submit Enough Signatures To Challenge Local Decriminalization Repeal, While Another City’s Reform Faces Lawsuit (Marijuana Moment)

Magic Mushrooms

• A single dose of psilocybin improves depression in treatment-resistant patients, but with adverse effects (PsyPost)

• Psilocybin Therapy For Autism-Like Disorder Receives Approval For Phase 2a Clinical Trial (The Dales Report)

• Do Shrooms Go Bad? (DoubleBlind)

MDMA

• MDMA Is Getting Super Popular Among Rich, Young Indians (VICE)

• VA Report Says Psilocybin And MDMA Show Therapeutic ‘Promise’ For Veterans’ Mental Health Conditions (Marijuana Moment)

DMT

• Phase 2a study initiated to examine synthetic DMT for treatment-resistant depression (Healio)

Ayahuasca

• “Nobody Wants A Synthetic-Only Future”: Filament Health Is Formulating Natural Psilocybin And Standardizing Ayahuasca (Healing Maps)

Novel Psychoactive Substances

• Tripping Without The Trip: Non-Hallucinogenic Psychedelics (Benzinga)

Ketamine

• Much remains unknown about using ketamine to treat depression—and Colorado doesn't regulate it (The Denver Post)

Miscellaneous

• New York Lawmakers File Psychedelics Legalization Bill For 2023 (Marijuana Moment)

• Psychedelics Like Psilocybin Are Now Legal In Colorado With Governor’s Proclamation On Voter-Approved Ballot Measure (Marijuana Moment)

• The Multidimensional Worlds of Mariela de la Paz (DoubleBlind)

• Minnesota Medical Association Endorses Decriminalizing Drugs (Marijuana Moment)

• Psychedelic therapies are on the horizon, but who will administer the drugs? (NBC News)

• Psychedelic drugs may launch a new era in psychiatric treatment, brain scientists say (NPR)

• Psychedelics Are Surging—at the Expense of Indigenous Communities (The Daily Beast)

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Month in Psychedelics - November 2022

Policy

The 2022 midterm elections caused November to be a monumental month for drug policy developments in the United States. While not every attempted effort was passed, many were successful. Kicking things off, Colorado voters approved a statewide measure to decriminalize natural psychedelics and create a model to legally purchase them. These changes will roll out gradually over the course of the next four years.

With nearly 70% of Americans in favor of legalizing cannabis, it’s no surprise that there were several victories in reforming cannabis policies across the country. Maryland and Missouri both legalized marijuana, becoming the 20th and 21st states to do so. Meanwhile, voters in Ohio, Wisconsin, and Texas approved a variety of cannabis-related drug policy reforms.

In addition to the midterm elections, bipartisan lawmakers in Congress formed a new first-of-its-kind “psychedelic caucus” which will “focus on exploring psychedelic research to alleviate the U.S. mental health crisis.” The congressional Psychedelics Advancing Clinical Treatments (PACT) caucus will not be advocating for drug policy reforms but will instead focus congressional conversations around the therapeutic potential of psychedelics and work toward educating lawmakers and the public.

Across the pond, the Netherlands is planning to ban nitrous oxide due to concerns that the drug will cause severe health issues in addition to the thousands of vehicular crashes the country has been experiencing between 2018 and 2021. The Dutch government is expected to confirm the ban on distribution, sale, and possession of nitrous oxide in January.

Industry

A psychedelic entrepreneur in Florida opened an above-board shroom dispensary. Well, sort of… rather than selling psilocybin mushroom products, the hemp dispensary is selling Amanita muscaria, the red-and-white dotted mushroom species that engenders psychoactive effects when consumed. This is yet another example of newly-formed businesses operating in legal gray areas involving psychoactive drugs, and it will be interesting to see if the shop is able to stay open now that word has spread about its trippy offerings.

Research

The final participant in the Multidisciplinary Association for Psychedelic Studies (MAPS) Phase 3 trial of MDMA-assisted therapy for PTSD completed their last session in the clinical treatment protocol, bringing the study to a close. The next step in the process will be an FDA evaluation of the treatment’s safety and efficacy, which will take place next year. It’s been a long ride for MAPS, which started the work of obtaining FDA approval to use MDMA therapeutically 36 years ago!

Compass Pathways published results from its Phase 2 clinical trial of psilocybin-assisted therapy for depression, and they left a little to be desired. Although the treatment yielded rapid antidepressant effects for most patients, only about 20% of participants still showed significant improvement at 12 weeks. These results are roughly as effective as existing SSRIs or traditional therapeutic treatments for depression like cognitive behavioral therapy.

A couple studies looking into ayahuasca found that the South American brew causes adverse side effects, but the benefits still outweigh the risks. This seems to me to be common sense, because the use of practically all psychedelics involves some negative side effects but as they say, “the juice is still worth the squeeze” in my opinion.

Harm Reduction

A survey analyzed responses from about 250,000 festival attendees and found that drug checking services create a safer environment. The study focused on both positive and negative impacts of on-site drug checking and concluded that not only did the service not result in an increase of drugs at festivals, but about 61% of people who used them disposed of drugs they were intending to take if they were unsure what they contained. In addition, the seven festivals that provided drug checking services did not incur a single drug-related death.

Miscellaneous

The U.S. National Park Service (NPS) issued a warning asking people to not lick toads that secrete 5-MeO-DMT, a psychedelic alkaloid present in the Sonoran desert toad. This messaging appears to have been shared even though there hasn’t been a noted increase in toad-licking happening in national parks. Besides, every psychonaut worth their salt knows that you don’t lick the toad, you smoke the extracted secretion! Nonetheless, it’s entertaining to see the U.S. government attempt to communicate with the public about psychedelic drugs, even if they aren’t getting all of the details right.

Wrapping up this month’s recap is a study of ancient human remains that found that a Nazca child consumed San Pedro cactus prior to being sacrificed in a ritual ceremony more than a thousand years ago. This is not the first study to find a history of psychedelic use prior to ritual sacrifice, indicating that this may have been a more widespread practice than it was once thought to be.

That’s all for this month’s update. Remember to always test and weigh your drugs and until next time—keep thinking wilder.

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Weekly Psychedelic Links - November 2022

11.4.22

Cannabis

• Legal cannabis is America’s 6th biggest cash crop (Leafly)

• Nevada Judge Orders Cannabis Removed From State’s List of Controlled Substances (High Times)

• Delaware’s Democratic Governor Vetoes Bipartisan Bill To Protect Medical Marijuana Patients’ Gun Rights (Marijuana Moment)

• Consumers embrace concentrates as falling flower prices lead to cheaper extracts (Marijuana Business Daily)

• Legal Marijuana Access Tied To Lower Risk Of Lung Injuries From Contaminated Vapes, Study Indicates (Marijuana Moment)

• Creator Explains Patented Process To Extract Cannabinoids From Smoke (High Times)

• New Senate Bill Would Create Federal Marijuana Commission To Prepare For Legalization (Marijuana Moment)

• Colorado Regulators Issue Recall for Moldy Weed (High Times)

• Missouri Voters Back Marijuana Legalization Ballot Initiative In New Poll, But Support Is Tightening A Week Before Election Day (Marijuana Moment)

• Arkansas Marijuana Legalization Initiative In Jeopardy, New Poll Shows Days Before Election (Marijuana Moment)

• Only a Quarter of Virginia Drivers Said Driving on Pot is ‘Extremely Dangerous,’ Survey Shows (High Times)

Magic Mushrooms

• Compass Pathways Phase 2 Psilocybin Results far from Spectacular (Psychedelic Spotlight)

• North America’s First Take Home Psilocybin Trial Approved in Canada (High Times)

• Colorado Psychedelics Legalization Ballot Initiative Still Trails But Picks Up Support From Previously Undecided Voters, New Poll Finds (Marijuana Moment)

• Therapists who already incorporate psychedelics in their practice are mixed on Prop 122 (CPR News)

MDMA

• The Ecstasy of Agony (Truthdig)

Ayahuasca

• Using Ayahuasca and Psychedelic Plants to Treat Racial Trauma (Psychology Today)

San Pedro

• Nazca Human Sacrifice Victim Used Psychedelics Before Death (High Times)

Ketamine

• New study provides insight into the cognitive mechanisms underlying ketamine’s rapid antidepressant effects (PsyPost)

• Telehealth startups prescribing ketamine at home are stirring concern (STAT News)

• Is Ketamine the Drug of the Moment? (VICE)

Miscellaneous

• MAPS Prepares For Trial in Wrongful Death Lawsuit (Lucid News)

• The Harms of Psychedelics Need to Be Put Into Context (WIRED)

• US veterans with PTSD turn to psychedelic drugs overseas as VA frustration grows (Yahoo!)

• Why San Francisco Didn’t (Really) Decriminalize Psychedelics (DoubleBlind)

• Why Humans Have Always Been Fascinated by Snakes—From Ayahuasceros to Egyptians (DoubleBlind)

• How Does Race and Ethnicity Influence Psychedelic Mental Health Outcomes? (Psychedelic Spotlight)

11.11.22

Cannabis

• Maryland Becomes 20th State to Legalize Marijuana for Adult Use (NORML)

• Missouri Becomes 21st State to Legalize Marijuana for Adult Use (NORML)

• Ohio Voters Approve Marijuana Decriminalization Ballot Measures In Five Cities (Marijuana Moment)

• Wisconsin Voters Approve Marijuana Ballot Questions In Cities And Counties Across The State (Marijuana Moment)

• South Dakota Voters Reject Adult-Use Cannabis Second Time Around (High Times)

• Arkansas Marijuana Legalization Initiative Defeated By Voters (Marijuana Moment)

• North Dakota Rejects Bill To Legalize Adult-Use Cannabis (High Times)

• Texas Voters In Five Cities Approve Marijuana Decriminalization Ballot Initiatives (Marijuana Moment)

• Can cannabis help us win the war against antibiotic resistance? (Salon)

• Czech Republic Plans To Legalize Cannabis In Coordination With Germany (Forbes)

• Wisconsin Governor Pledges To Put Marijuana Legalization In Upcoming Budget After Voters Approve Reform On The Ballot (Marijuana Moment)

• Minnesota Senators Signal Plans To Advance Marijuana Legalization In 2023 With New Democratic Majority (Marijuana Moment)

• Arkansas Activists Plan Expanded 2024 Marijuana Ballot Initiative Following This Week’s Legalization Defeat (Marijuana Moment)

• Judge Tosses Out Lawsuit on Rule Barring Medical Cannabis Users From Buying Guns (High Times)

• FDA Finally Rejects Petition For Federal Exemption For Marijuana More Than A Decade After It Was Filed (Marijuana Moment)

• ‘Cannabis Use Disorder’ Pill Clinical Trial To Begin (High Times)

• Study Shows Smoking Weed Doesn’t Automatically Make You Cool (High Times)

• New Survey Details The Growing Importance Of Cannabis For Thanksgiving Celebrations (Forbes)

• Study Finds No Change in Cannabis Perception Among Youth in Adult-Use States (High Times)

LSD

• LSD induces both an “afterglow” for memory performance and a cognitive “hangover,” study finds (PsyPost)

• LSD Microdosing Yields Positive Outcomes In Phase 1 Study, More Trials On Depression & Existential Distress (Benzinga)

Magic Mushrooms

• Several rural Oregon counties vote against therapeutic use of psilocybin (OPB)

• There’s Now a Shroom Dispensary in the US (DoubleBlind)

• The Heroic Dose: Navigating Powerful Mushroom Journeys (DoubleBlind)

MDMA

• MDMA Therapy is Almost Legal—But Who Will Have Access? (DoubleBlind)

• ‘Losing the Magic’: When MDMA Just Stops Working (VICE)

Ayahuasca

• Ayahuasca to blame for Aaron Rodgers' struggles, ESPN's Robert Griffin III suggests (Fox News)

• What Mainstream Churches Can Learn from an Ayahuasca Church (Lucid News)

5-MeO-DMT

• Feds Tell National Park Visitors To Stop Licking Psychedelic Toads (Marijuana Moment)

Novel Psychoactive Substances

• 5-HT2A Virtual Chemical Screen Produces New Candidate Antidepressants (Psychedelic Science Review)

Synthetic Cannabinoids

• Two hospitalised due to dangerous batch of synthetic cannabinoids (Stuff.co.nz)

Nitrous Oxide

• Home Office responds to call for retail sales ban on nitrous oxide (gasworld)

Ketamine

• Mom of 5 died after ketamine injection by a paramedic, family alleges in wrongful death suit (NBC)

Miscellaneous

• What a Trip: Coloradans Approve Landmark Psychedelics Measure (Westword)

• Wonderland Miami Exposes Growing Rift in Psychedelic Community (Psychedelic Spotlight)

• Psychedelic Training Provider Fluence Files Trademark for Common Phrase, Walks Back After Criticism (Psymposia)

• Psychedelic drug research held back by UK rules and attitudes, say scientists (The Guardian)

• Will the Psychedelic Revolution Be Medicalized? (Lucid News)

11.18.22

Cannabis

• Kentucky Governor Signs Executive Orders Allowing Medical Marijuana Possession From Other States And Regulating Delta-8 THC (Marijuana Moment)

• Congress Passes Landmark Cannabis Research Bill (High Times)

• Half of Dentists Say Patients Arrive to Checkups Stoned, Survey Finds (High Times)

• Nearly Seven In Ten Americans Back Marijuana Legalization, Including Majority Of Republicans, Latest Gallup Poll Finds (Marijuana Moment)

• Cows Given Hemp Feed To Produce Milk With THC (High Times)

• New York’s gray market cannabis crackdown begins in Brooklyn (Leafly)

• Study Finds Link Between Cannabis Use, Greater Physical Activity in HIV+ Patients (High Times)

• U.K. Researchers Launch Study Exploring Weed’s Effects on the Brain (High Times)

• Study Examines If CBD Buffers THC’s Effects (High Times)

Magic Mushrooms

• Nearly 70% of Oregon bans psilocybin, but clinics will still open next year (Leafly)

MDMA

• Second MAPS-Sponsored Phase 3 Trial of MDMA-Assisted Therapy for PTSD Completed (MAPS)

• Post-pandemic trends in the UK MDMA market and implications for harm reduction services (Volteface)

DMT

• Algernon Pharmaceuticals begins screening of first subject in phase 1 DMT human stroke study (Pharmabiz)

Ayahuasca

• Mind-altering South American brew causes adverse side effects, study says (UPI)

Novel Psychoactive Substances

• VIC Health Warns of 'Chemical Similar to PCP' Sold as Ketamine (VICE)

Nitrous Oxide

• Laughing Gas Is Being Banned In the Netherlands As Reports of Extreme Use Grow (VICE)

Ketamine

• Online Ketamine Clinics Face Tougher Times After Covid-Era Boom (Bloomberg)

Miscellaneous

• Bipartisan Lawmakers Form New Psychedelics Caucus In Congress (Marijuana Moment)

• Drug testing makes festivals safer, new research finds (Mixmag)

• Spiraling Down Wonderland’s Psychedelic Corporate Rabbit Hole (Lucid News)

• ‘How to Change Your Mind’ and the Destigmatisation of Psychedelics (Sam Woolfe)

• Elon Talks Psychedelics: Is he Helping or Hurting the Movement? (Microdose)

• Psychedelic drugs may reopen critical learning periods in the brain (New Scientist)

• Cory Booker And Rand Paul File Bill To Reschedule Psychedelic Breakthrough Therapies And Remove Research Barriers (Marijuana Moment)

• Philadose conference highlights psychedelic therapies in Pennsylvania (The Philadelphia Inquirer)

• Inside Detroit’s Trippy A-F “Psychedelic Healing Shack” (DoubleBlind)

• Would you let your teenager try psychedelics? (Drug Science)

11.25.22

Cannabis

• Krispy Kreme is paying to keep weed illegal (Leafly)

• Rhode Island To Begin Adult-Use Cannabis Sales on Dec. 1 (High Times)

• Oregon: Governor Announces Mass Pardons for Those with Low-Level Cannabis Convictions (NORML)

• Colombian Senators Approve Marijuana Legalization Bill (Marijuana Moment)

• North Carolina tribe begins first legal medical cannabis harvest in the state (Marijuana Business Daily)

• Irish Lawmaker Files Bill To Legalize Marijuana Possession For Adults, Draws Early Criticism From Top Government Official (Marijuana Moment)

• CBD did not help people who got too high, study finds (Leafly)

• New York Cannabis Farms Have $750 Million of Weed — and Nowhere to Sell It (Bloomberg)

• Just 10 Percent Of Americans Think Marijuana Should Be Totally Illegal, Pew Poll Finds (Marijuana Moment)

• Cops May Soon Be Able To Scan Your Eyeballs To See if You’re Driving Stoned (High Times)

• South Dakota Medical Marijuana Patients Won’t Be Denied Hunting Licenses, Official Says (Marijuana Moment)

• The Nose Knows! Study Shows Aroma Drives Cannabis Consumer Appeal (High Times)

• Federally Funded Study Shows Marijuana Legalization Is Not Associated With Increased Teen Use (Marijuana Moment)

• Southern Illinois University Examining the Use of Cannabis for Ovarian Cancer (High Times)

• No, marijuana is not more harmful than tobacco (Leafly)

• Idaho Activists Launch Signature Drive To Put Medical Marijuana Legalization On 2024 Ballot (Marijuana Moment)

LSD

• Beckley Foundation Announces LSD, Microdosing Research (High Times)

Magic Mushrooms

• Oregon's Newly Legal Magic Mushroom Industry Could Be Strangled by Restrictive Zoning Regulations (Reason)

Ayahuasca

• Study Finds Benefits Outweigh Risks of Ayahuasca Use (High Times)

5-MeO-DMT

• Psychedelic Brains In A Dish (Psychedelic Science Review)

Iboga

• I Tried Ibogaine, the Psychedelic Anti-Addiction Drug (VICE)

Synthetic Cannabinoids

• Utah moves to ban synthetic cannabinoids in medical marijuana products (Fox 13)

Ketamine

• Long-term Ketamine Treatment for Depression May Reduce Risk of Relapse (Lucid News)

• At-Home Ketamine Treatments Could Be a Game-Changer—or a Big Problem (Gizmodo)

• Amygdala connectivity predicts ketamine treatment response among patients with anxious depression (PsyPost)

• atai Life Sciences and Massachusetts General Hospital Announce Initiation of Clinical Study Investigating Neuroplasticity Biomarkers in Treatment-Resistant Depression Patients Undergoing Ketamine Treatment (Psychedelic Alpha)

Miscellaneous

• There’s a Worldwide Spike in Arrests of Plant Medicine Practitioners (DoubleBlind)

• All Entheogens Welcome at this Post-Modern Oakland Church (Lucid News)

• How To Stop A Psychedelic Trip: The Promise of Ketanserin (Psychedelic Science Review)

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

Weekly Psychedelic Links - October 2022

10.7.22

Cannabis

• Biden Announces Mass Marijuana Pardons And Calls For Cannabis Scheduling Review (Marijuana Moment)

• Amsterdam considers banning ‘cannabis tourists’ from its coffee shops (The Guardian)

• Costa Rica’s President Sends Marijuana Legalization Bill To Lawmakers (Marijuana Moment)

• 'It's like the new Amsterdam': The rush to cash in on Thailand's hazy cannabis laws (Australian Broadcasting Corporation)

• FBI: Nearly Half of All Drug Seizures in 2021 Involved Marijuana (NORML)

• Morocco issues first permits for cannabis production (Reuters)

• Committee in Colombia Approved Adult-Use Legalization Proposal (High Times)

• Most Americans Don’t Think Marijuana Is Dangerous Despite Prohibitionist Arguments, Poll Finds (Marijuana Moment)

• Regulators finally approve hempcrete for US homes (Leafly)

• OSHA report ties cannabis worker death to dust inhalation (Leafly)

• Survey: Medical Students Rarely Exposed to Scientific Data About Cannabis (NORML)

Magic Mushrooms

• Oregon enters the home stretch to authorize psilocybin mushrooms (Chacruna)

• This 'magic' mushroom dispensary in Florida is selling psychedelics and testing legal boundaries (Business Insider)

MDMA

• MindMed Collaborators Initiate Phase 1 Comparative PK/PD Trial of R-, S- and Racemic MDMA (Psychedelic Alpha)

DMT

• Prolonged DMT Infusions could be a Breakthrough for Stroke Patients (Psychedelic Spotlight)

Ayahuasca

• Combating Suicidality: A Role for Psilocybin and Ayahuasca? (Psychedelic Science Review)

Novel Psychoactive Substances

• These LSD-based drugs seem to help mice with anxiety and depression — without the trip (NPR)

• Are you too high? A promising new ‘comedown drug’ may be on the way (Leafly)

Synthetic Cannabinoids

• Unexplained Bleeding Linked to Rat Poison in Synthetic Cannabinoids (Medpage Today)

Nitrous Oxide

• Nitrous oxide: Southend mum's campaign over 'laughing gas' (BBC)

Ketamine

• Ketamine and depression: A mechanism of the antidepressant revealed (Medical Xpress)

• PharmaTher Holdings Announces Grant of U.S. Patent Covering Ketamine for Parkinson’s Disease (Psychedelic Alpha)

Miscellaneous

• Alberta to be 1st province to regulate psychedelics for therapy, government says (CBC)

• DEA Admits ‘Racial, Ethnic and Class Prejudice’ Led To Drug Criminalization And The Agency’s Own Founding (Marijuana Moment)

• New York Lawmakers File Amended Psychedelics Legalization Bill, With New Regulations And Protections (Marijuana Moment)

• Psychedelics may flatten your brain’s landscape, but in a good way (Leafly)

• Inflammation Nation: How Psychedelics Could Combat Widespread Chronic Pain (Psychedelics Today)

• Psychedelics: Will Policy Liberalization and Lower Barriers to Access Lead to Future Legalization? (Lexpert)

• Psychedelics are exploding in the startup community as founders say it makes them better leaders (Fortune)

• Timothy Leary’s psychedelic eugenics (Medium)

• Eleusis Holdings Plans To Be Acquired By Beckley Psytech (Lucid News)

• ‘Bad’ Psychedelic Trips Don’t Have To Be Bad (VICE)

10.14.22

Cannabis

• Colombian Chamber Of Representatives Passes Marijuana Legalization Bill In Initial Vote, With Support From Cabinet Ministers (Marijuana Moment)

• U.S. Air Force to Allow Applicants to Retest After Positive THC Test (High Times)

• Why bees love weed — and why it might even be good for them (Salon)

• Cannabis Stock’s Post Pardon Depression Could Be Cured By Lame Duck Legislation (Forbes)

• New Study Shows Cannabis Users More Likely To Have Overactive Bladders (High Times)

• Federal Reserve Bank Says Marijuana Legalization Drives Tax Revenue, Job Creation And Real Estate Sales (Marijuana Moment)

• Spliff Vape: New Tech Allows Cannabis, Nicotine To Be Vaped Simultaneously (High Times)

Magic Mushrooms

• Flight Passenger on Mushrooms Causes Chaos Mid-Flight (High Times)

• Can Psilocybin Challenge Our Pharmaceutical Dependence? (Vogue)

MDMA

• Eels Living Near Music Festivals Test Positive For MDMA And Cocaine (IFLScience)

Synthetic Cannabinoids

• Synthetic Marijuana In Florida Tainted With Rat Poison, 52 Sick, 4 Dead (Forbes)

• Five-Year-Old Missouri Child Gets Delta-8 Edibles in Halloween Bag (High Times)

Nitrous Oxide

• Nitrous Oxide: Harm Reduction and the Muslim Community (VolteFace)

Miscellaneous

• These States Are Voting On Marijuana And Psychedelics Legalization On Their November Ballots (Marijuana Moment)

• Elon Musk reportedly goes on 'exploratory journeys' and likes to show friends a chart of the benefits of MDMA and mushrooms over alcohol (Business Insider)

• To Standardize Psychedelic Therapy, A New Organization Launches (Forbes)

• Horizons Conference Returns to NYC for Its 15th Year (Lucid News)

• Treating postpartum depression with psychedelics (The Print)

• A Santo Daime Church’s Legal Success Paved a Path Towards Psychedelic Legalization (Lucid News)

• Instagram’s Page-Deletions of Black Women in Psychedelic Advocacy (Filter)

• Math Over Myth: These Psychedelic Stocks Made Confirmed Bottoms in Q3 (Psychedelic Spotlight)

• What Made María Sabina Unique (DoubleBlind)

• The Politics of Psychedelics: Legalisation vs Decriminalisation (Sam Woolfe)

10.21.22

Cannabis

• German cannabis legalisation plans LEAKED (VolteFace)

• Washington DC lets tourists self-certify for medical cannabis (Leafly)

• Poll: Two-Thirds of Voters Say “Nobody Should Be in Jail” for Marijuana Possession (NORML)

• States With the Most Arrests for Marijuana Possession (U.S. News and World Report)

• Why does marijuana make it hard to remember stuff? (Salon)

• NBA Won’t Test Players For Marijuana For Third Season In A Row, Report Says (Marijuana Moment)

• Nearly Four Out of Five Patients Drop or Reduce Opioids After Using Medical Weed (High Times)

• Brazilian Federal Council of Medicine Bans CBD Prescriptions for Adult Patients (TalkingDrugs)

• Cannabis Had Highest Tax Revenue in Colorado and Washington Over Alcohol, Cigarettes (High Times)

• Marijuana was illegal 4 years ago. Now, Uber Eats delivers it in Toronto (CBC)

• Missouri Police Object To New Ad For Marijuana Legalization Ballot Initiative That Shows Officers (Marijuana Moment)

• Oklahoma Governor Sets March Special Election for Weed Legalization Initiative (High Times)

• Texas Activists Unveil Marijuana Decriminalization, Police Reform And Abortion Rights Initiative For San Antonio 2023 Ballot (Marijuana Moment)

• Puerto Rico Bill Would Expunge Low-Level Weed Possession Convictions (High Times)

LSD

• Acid for Anxiety: Fast and Lasting Anxiolytic Effects of LSD (Psychedelic Science Review)

• A Communist LSD Trip: The Story of Czechoslovak Acid (Prague Morning)

Magic Mushrooms

• Oregon is voting on medical psilocybin, again (Leafly)

• NYC smoke shops are selling magic mushroom candy bars (New York Post)

• Study To Examine Why Shrooms Evolved with Psychedelic Properties (High Times)

• Why Everyone Cares So Much About Colorado’s Psilocybin Bill (DoubleBlind)

MDMA

• MDMA-assisted psychotherapy shows promise in the treatment of eating disorder symptoms (PsyPost)

5-MeO-DMT

• The toad boom: the false narrative of ancestral 5-MeO-DMT use (Points)

Novel Psychoactive Substances

• Scientists Discover ‘Disconcerting’ New Imitation Ketamine on the Market (VICE)

Synthetic Cannabinoids

• New novel drug test can identify latest synthetic cannabinoids (Cannabis Health News)

Ketamine

• Ketamine May Reduce Suicidal Ideation in Treatment-Resistant Depression (Psychiatry Advisor)

Miscellaneous

• Australian Lawmakers Approve Drug Decriminalization Bill For Federal Territory That Includes Nation’s Capital (Marijuana Moment)

• DEA Proposes Dramatic Increases In Marijuana And Psychedelics Production In 2023 For Research (Marijuana Moment)

• Large national survey suggests that the use of psychedelics is not associated with lifetime cancer development (PsyPost)

• Will Medical Insurers Agree to Cover Psychedelic Trips? (Bloomberg)

• Why is the American right suddenly so interested in psychedelic drugs? (The Guardian)

• Second United States Patent Granted for Small Pharma’s Psychedelics Portfolio (Psychedelic Alpha)

10.28.22

Cannabis

• Germany’s Government Approves Marijuana Legalization Plan, But Reform Depends On European Union Sign-Off (Marijuana Moment)

• Russian court upholds Brittney Griner’s sentence (Leafly)

• Biden's Marijuana Pardons Did Not Free a Single Federal Prisoner or Deliver the Expungement He Promised (Reason)

• Activist Arrested At White House Protest Pushing Biden To Release Marijuana Prisoners (Marijuana Moment)

• Missouri’s legalization measure is drawing unexpected opposition (Leafly)

• Five States To Vote on Recreational Cannabis This Election Season (High Times)

• Most Americans Say Alcohol And Tobacco Are More Dangerous Than Marijuana, Poll Finds (Marijuana Moment)

• California Lawsuit Alleges Weed Didn't Get Plaintiffs High Enough (VICE)

• Research: Does Cannabis Really Make You More Creative? (Harvard Business Review)

• Israeli Company Clones Cannabis Cells—Not Plants—With Up to 12 Times the Potency (High Times)

• It's not a myth: Marijuana really is more potent than it used to be (Salon)

• Study: Cannabis Use Not A Risk Factor in Liver Transplants (High Times)

• Strange Bedfellows Team Up To Oppose Missouri Marijuana Legalization Ballot Measure (Marijuana Moment)

• Research Shows Cannabis Users Experience More Pain After Surgery (High Times)

• Support For Arkansas Marijuana Legalization Initiative Falls To Slim Majority As GOP Lawmakers Urge Opposition, Poll Finds (Marijuana Moment)

• How does THC affect prenatal development? (Leafly)

Magic Mushrooms

• The world's first Phase 3 psilocybin clinical trial is about to commence (New Atlas)

• DEA Faces New Legal Challenges Over Denying Psilocybin Rescheduling Petition And Doctor’s Federal Waiver Request (Marijuana Moment)

• New Study Will Explore Psilocybin as a Treatment To Stop Smoking (High Times)

• N.S. company launching clinical trial to examine magic mushrooms as treatment for PTSD (CBC)

• The Potential Health Benefits of Microdosing Psilocybin With Chocolate (Psychology Today)

• Psilocybin Common Denominator in Several Recent Albums (High Times)

DMT

• Algernon Pharmaceuticals Enters into a Clinical Trial Agreement with Yale University for a DMT Phase 2 Depression Study (Psychedelic Alpha)

Ayahuasca

• Couple Sentenced to Eight Years for Czech Ayahuasca Ceremonies (Psychedelic Spotlight)

• A Legal Ayahuasca Church Thrives in Southern California (Lucid News)

Peyote

• Native American Church Asks Congress for Peyote Funding (DoubleBlind)

Novel Psychoactive Substances

• WTF is 3-MMC, Berlin’s Weird New Club Drug? (DoubleBlind)

• Electric Picnic drug testing finds 'new psychoactive substances' never seen before in Ireland (The Irish Mirror)

Synthetic Cannabinoids

• Utah Medical Cannabis Flooded With Synthetic Cannabinoids From Hot Hemp (Forbes)

Ketamine

• Electroconvulsive Therapy Could Be Better Than Ketamine At Treating Depression (IFLScience)

Miscellaneous

• Beckley Psytech Strengthens Pipeline and Development Team With Acquisition of Eleusis Therapeutics Limited (Psychedelic Alpha)

• People Who Use Psychedelics Are More Connected To Nature And Knowledgeable About Climate Change, Study Finds (Marijuana Moment)

• Use of Psychedelic Therapies for Treatment Resistant Patients Again Rejected by Government, Despite Strong Supporting Safety and Efficacy Data and Australia’s Worsening Mental Health Crisis (Mind Medicine Australia)

• With Promise of Legalization, Psychedelic Companies Joust Over Future Profits (The New York Times)

• Manipulating light can induce psychedelic experiences – and scientists aren’t quite sure why (The Conversation)

• The ideological war at the heart of the psychedelic renaissance (New Atlas)

• Research, remedy and regulation: the changing dynamics of psychedelic therapy in Alberta (CBC)

• An Exploration of Psychedelics and Creativity (Drug Science)

• Variants in 5-HT2A Receptor Gene Alter Psychedelic Pharmacology (Psychedelic Science Review)

• Guidelines for Ethical Sponsorship and Transparency in Psychedelic Conferences (Chacruna)

• Terence McKenna's secret bad trip (Ecstatic Integration)

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

Weekly Psychedelic Links - August 2022

8.5.22

Cannabis

• Brittney Griner sentenced to 9 years in Russian prison for drug possession and smuggling (Leafly)

• Another American Caught With Weed in Russia Sentenced to 14 Years in Prison (High Times)

• Cannabis no more of a risk than tobacco and alcohol – study (Cannabis Health News)

• Federal Marijuana Records Would Be Expunged Under New Bipartisan Congressional Bill (Marijuana Moment)

• New Study Says Legalization Hasn’t Caused More Teens To Try Cannabis (Marijuana Moment)

• Cannabis Cafes Emerge in Post-Legalization Thailand (High Times)

• Study Shows Cannabis Users 55% Less Likely to Develop Common Liver Cancer (High Times)

• Arkansas Marijuana Campaign Files Lawsuit To Put Legalization Measure On Ballot After State Board’s Rejection (Marijuana Moment)

• US weed homegrowers produce 8x more than Colorado legal market, says new report (Leafly)

• Feds Seek Contractor To Help Test Marijuana Compounds In People’s Breath (Marijuana Moment)

• New 3D Structures of Cannabinoid Receptor Inform Safer Drug Design (Psychedelic Science Review)

• New Report Recommends Tips for Successful Cannabis-Impaired Driving Campaigns (High Times)

• Colleges In States That Legalize Marijuana See A Boost In Application Numbers, Study Finds (Marijuana Moment)

• Brazilian Government’s Selective Blindness to Cannabis Evidence (TalkingDrugs)

• Largest Federal Workers Union Calls For Ending Marijuana Tests For Most Government Employees In Legal States (Marijuana Moment)

LSD

• Medidosing LSD: The Middle Way (Lucid News)

Magic Mushrooms

• Psilocybin Microdosing Shows No Benefit to Creativity, Cognition, Perception in New Scientific Study (Willamette Week)

• Oregon Psilocybin Rules Set To Be Finalized in December (High Times)

• Lead Plaintiff in Canadian Right To Try Lawsuit Shares His Psilocybin Story (Lucid News)

• The Rise of Casual Shrooms (VICE)

MDMA

• It’s Festival Season! How Should We Group Dose MDMA? (Lucid News)

DMT

• The Real Reason Cybin Bought Entheon’s DMT Clinical Trial (Psychedelic Spotlight)

Ayahuasca

• Study to Analyze Ayahuasca for Refugee Trauma (DoubleBlind)

• Aaron Rodgers Opens Up About Use of Psychedelics, Mental Health (Sports Illustrated)

Mescaline

• Mescaline: A Neglected Tool for Psychotherapy (Sam Woolfe)

Peyote

• The Peyote Plot: The Indigenous Fight to Conserve the Sacred Plant and the Spiritual Medicine it Contains (DoubleBlind)

Synthetic Cannabinoids

• Drug testers warn of new synthetic cannabinoid being sold as MDMA (The New Zealand Herald)

Ketamine

• Double-action mechanism found that makes ketamine less addictive (New Atlas)

• How ketamine chic became the new heroin chic (Dazed)

Miscellaneous

• Poll States 28% of Americans Have Tried At Least One Psychedelic Substance (High Times)

• The Need for 100,000 Psychedelic Facilitators is Real (LA Weekly)

• Morgan Stanley Publishes Optimistic Report on Psychedelics (Psychedelic Alpha)

• California Bills To Legalize Psychedelics Possession, Allow Interstate Marijuana Commerce And More Teed Up For Key Hurdle Next Week (Marijuana Moment)

• MindMed Board of Directors Approves Reverse Share Split (Psychedelic Alpha)

• Majority Of Americans Support Psychedelics Research For Military Members, New Poll Finds As Bipartisan Reform Advances In Congress (Marijuana Moment)

8.12.22

Cannabis

• Report: Spike in Marijuana Positives Fueling Truck Driver Shortage, Supply Chain Disruptions (NORML)

• Ottawa on track to spend $200M per year on cannabis for veterans (CBC)

• Wisconsin Governor Pardons Several for Cannabis Offenses (High Times)

• Missouri will vote on marijuana legalization in November (Leafly)

• Arkansas Supreme Court Orders State To Put Marijuana Legalization Initiative On Ballot, But Votes May Not Be Counted (Marijuana Moment)

• Colorado Marijuana Shops Are 98 Percent Compliant With ID Checks To Prevent Underage Sales, State Regulators Say (Marijuana Moment)

• Cannabis And Lower COVID Hospitalizations: Is There A Connection? Here’s What A New Study Found (The Fresh Toast)

• Biden DOJ Says Medical Marijuana Patients Are Too ‘Dangerous To Trust’ In Motion To Dismiss Lawsuit On Gun Rights (Marijuana Moment)

• Voters Across Wisconsin Will See Marijuana Questions On Their Ballots In November (Marijuana Moment)

• ‘Very good for tourists’: Thailand aims for high season with U-turn on cannabis (The Guardian)

• The (Possibly) Best and Worst Countries To Get Caught With Pot (Benzinga)

• New Florida Marijuana Legalization Initiative Filed For 2024 Ballot, With Backing Of State’s Largest Medical Cannabis Company (Marijuana Moment)

• Can memory loss be good? How cannabis can help with PTSD (Leafly)

• Arresting illicit weed sellers repeats our drug war mistakes (NJ.com)

LSD

• Neuroscience research suggests LSD might enhance learning and memory by promoting brain plasticity (PsyPost)

Magic Mushrooms

• Psilocybin therapy is prompting states to reconsider laws about magic mushrooms (USA Today)

• Many Oregonians will have to vote again on psilocybin (Oregon Capital Chronicle)

• Buried Treasure: How Does Psilocybin Reduce Compulsivity? (Psychedelic Science Review)

• Can Psilocybin Treat Obesity? New Evidence, Future Directions (Psychedelic Science Review)

• Inside the lab that's creating enough psilocybin for everyone on Earth (Wisconsin Public Radio)

• Phase 2 clinical trial to examine efficacy of psilocybin for anorexia nervosa (Healio)

• Coos County cities move to ban psilocybin for medical use in their communities (KCBY)

• Optimi Health To Launch Therapeutic Psilocybin Product In Partnership With Patient Advocate Thomas Hartle (Psychedelic Alpha)

MDMA

• Las Vegas Wastewater Study Finds Absolutely Bonkers Spike In MDMA Levels During EDC (BroBible)

• Where Ecstasy Meets Power: The Unique Risks of MDMA Therapy (Sam Woolfe)

Ayahuasca

• Packers’ Aaron Rodgers Won’t Be Disciplined for Using Psychedelic Drug (Sports Illustrated)

• Aaron Rodgers’ former Packers QB coach reacts to psychedelic drug revelation (New York Post)

Novel Psychoactive Substances

• Psilera’s New Compounds Show Potential for Significant Treatment Improvement in Depression and Neurodegenerative Disorders (Psychedelic Alpha)

• Majority of 'Bath Salt' Deaths Concentrated in Just Two States (Medpage Today)

• Woman likely drowned after taking hallucinogenic drugs, coroner finds (Stuff.co.nz)

Synthetic Cannabinoids

• States That Legalize Marijuana See ‘Significant Reductions’ In Synthetic Cannabinoid Poisonings, Study Finds (Marijuana Moment)

• A 'very unpleasant time' - new synthetic drug in NZ (Radio New Zealand)

Nitrous Oxide

• Urgent warning to parents over teens inhaling nitrous oxide after canisters found across Dublin (The Irish Sun)

Ketamine

• How The Brain Changes In People With Chronic PTSD Following Ketamine Treatment (Healing Maps)

Miscellaneous

• VR is as good as psychedelics at helping people reach transcendence (Technology Review)

• The DARE Program Is Back in Some School Districts — Here’s What to Know (Teen Vogue)

• Compass Pathways Sued for Stealing Trade Secrets (Psychedelic Spotlight)

• An initiative to decriminalize most plant-based psychedelics is likely to fall short on signatures (Colorado Public Radio)

• Colombia’s New President Wants to End the Drug War. Can He Succeed? (Filter)

• Bear high on hallucinogenic 'mad honey' rescued in Turkey (Irish Mirror)

• How Do We End the ‘War on Drugs’? Perhaps Scandinavia Has the Answer.. (Volteface)

• Psychedelics are having a moment and women could be the ones to benefit (MIT Technology Review)

• Over the counter culture: Are psychedelics coming to the corner shop? (The Independent)

• Psychedelics researchers and investors should focus on delivering therapy, not drugs (STAT)

• Muslims on Drugs: Psychedelics, Queerness, and Identity in the Post-9/11 Era (DoubleBlind)

• What Role does Philosophy Play in the Future of Psychedelics? (TalkingDrugs)

• First Reddit Community-Led Scientific Study to Launch on Quantified Citizen (Yahoo!)

• Red Wall Voters Want Drug Law Reform – New Polling Shows (Volteface)

• Psychedelic Clinical Trials and the Michael Pollan Effect (Psychedelic Spotlight)

• Young Psychedelic Philanthropist Blazes Path for the Psychedelic Future (Lucid News)

• Rediscovering Our Ancestral Roots of Exploration (Chacruna)

• What Happens when Psychedelics Meets Video Games? (Lucid News)

8.19.22

Cannabis

• Brittney Griner Appeals Conviction in Russian Drug Case (High Times)

• North Dakota will vote on cannabis legalization in November (Leafly)

• Arkansas court orders recreational cannabis amendment put back on ballot (Marijuana Business Daily)

• Pot-smoking tourists not welcome in Thailand, says health minister (Reuters)

• South Dakota Reservation Bans Alcohol, Allows Cannabis (High Times)

• Analysis: Racial Disparities in Marijuana Possession Arrests Becoming More Pronounced in Prohibition States (NORML)

• ‘Clean weed’ is about to be everywhere in California. Here’s what you need to know (Los Angeles Times)

• Ohio Voters In Seven More Cities Will Decide On Marijuana Decriminalization At The Ballot This November (Marijuana Moment)

• Idaho Activists Launch Medical Marijuana Ballot Push For 2024 (Marijuana Moment)

• Alberta cannabis sales slow to grow as online identity verification deters consumers, say retailers (CBC)

• Gallup: Those with First-Hand Experience with Cannabis Likely to Perceive It Positively (NORML)

• Majority Of Texas Voters Support Marijuana Legalization, Poll Finds (Marijuana Moment)

• Most Wisconsin Voters—Including Republicans—Support Legalizing Marijuana, Poll Shows (Marijuana Moment)

Magic Mushrooms

• Is Oregon Ready for the Coming Psilocybin-Fueled Mushroom Tourism Boom? (Portland Monthly)

• Optimi Health Unveils Canada’s First Natural Therapeutic Psilocybin Product For Approved Patients (Psychedelic Alpha)

MDMA

• Warnings over dangerously high-strength MDMA pills found at Boardmasters (Mixmag)

DMT

• Small Pharma Receives Approval for DMT-Assisted Psychotherapy and SSRI Drug Interaction Study (Psychedelic Alpha)

Ayahuasca

• The Misfortune of “Right Wing” Psychedelia” in Brazil (Chacruna)

• Anonymous Letter to Conservative Masters of the UDV (Chacruna)

Novel Psychoactive Substances

• MindMed Shelves 18-MC for Opioid Use Disorder and Further Cuts Pipeline (Psychedelic Spotlight)

Nitrous Oxide

• Atlanta neighbors frustrated by nitrous oxide use outside Widespread Panic show (KMIZ)

Ketamine

• We Asked the Experts: What Exactly is in Ketamine? (TalkingDrugs)

Miscellaneous

• Video of a forester who found a drunken bear gorged on hallucinogenic honey became a hit on the Internet (The Saxon)

• California Psychedelics Legalization Bill Gutted by Key Committee (DoubleBlind)

• Psychedelics as a sacrament? Lawsuit says drugs are a religious right. (The Washington Post)

• Integration of psychedelic experiences linked to self-actualization via improvements in personal development and self-insight (PsyPost)

• Two In Five Americans Say They’ve Changed Their Mind On Drug Policy, With Most Becoming “More Liberal,” Poll Finds (Marijuana Moment)

8.26.22

Cannabis

• Federal Trade Commission issues refunds to CBD buyers, here’s why (Leafly)

• Nebraska Officials Will Take A Second Look At Signatures For Rejected Medical Marijuana Ballot Measures (Marijuana Moment)

• New medical marijuana campaign launches in Idaho for 2024 ballot (Marijuana Business Daily)

• Study Shows 20% Increase in Frequency of Cannabis Consumption in Recreational States (High Times)

• FBI Says CBD Use Is An ‘Automatic Disqualifier’ For Employment Despite Federal Hemp Legalization (Marijuana Moment)

• Oklahoma’s legalization initiative at risk due to state delay (Leafly)

• The casualties of California legalizing pot: Growers who went legal (The Washington Post)

• U.S. Forest Service Reminds Workers Of Federal Marijuana Ban And Warns Against CBD Use (Marijuana Moment)

• Dennis Rodman Proposes To Negotiate Russia Brittney Griner Release (High Times)

• Why The Legal Cannabis Industry Needs The Black Market (Forbes)

• Legalization Opponents Sue To Block Initiative From Missouri Ballot (High Times)

• Cannabis for Chronic Pain Linked to Slightly Increased Risk of Arrhythmia (Healthline)

LSD

• First Patient Dosed in Trial of LSD for Generalized Anxiety Disorder (Psychiatric Times)

Magic Mushrooms

• Psilocybin May Help Treat Alcohol Addiction, Study Shows (TIME)

• Three Out Of Four Oregon Counties Will Vote On Banning Or Postponing Psilocybin Services This November (Marijuana Moment)

• Inside Paul Stamets’ Massive Microdosing Study (DoubleBlind)

Ayahuasca

• Mormon Bishop And Former GOP Utah Rep. Champions Ayahuasca After Faith-Affirming Psychedelic Experience (Marijuana Moment)

5-MeO-DMT

• Trip Advisors: Group Promotes 5-MeO-DMT Harm Reduction By Exposing Shamanic Hustlers (Forbes)

Novel Psychoactive Substances

• The DEA is Attempting to Ban Two New Psychedelic Drugs (Psychedelic Spotlight)

• Clearmind Medicine Announces Additional Positive Pre-Clinical Results for its Cocaine Addiction Treatment (Psychedelic Alpha)

• BetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity with Possible Nootropic Effects Similar to That of LSD Without Hallucinogenic Side Effects (Psychedelic Alpha)

Nitrous Oxide

• Laughing Gas During Labor Is Becoming More Popular Among Women in the United States (People)

Ketamine

• Ketamine’s upgrade to an employee benefit in US may hasten the legitimacy of psychedelics in SA (BizNews)

DXM

• FDA Approves First, Only NMDA Receptor Antagonist for Major Depressive Disorder (Pharmacy Times)

Miscellaneous

• Psychedelic Stocks: MindMed and atai Slash their Pipelines, Mydecine Collapses (Psychedelic Spotlight)

• Psychedelics Use Increasing Among Adults, But Decreasing For Teens, New Federally Funded Studies Find (Marijuana Moment)

• Psychedelic-occasioned mystical experiences linked to increased pro-environmental behaviors (PsyPost)

• How near-death experiences and psychedelics alter attitudes about death (EurekAlert!)

• Does Microdosing Actually Work? The Science Is Still Conflicted (VICE)

• Issues of Patient Safety and Ethical Violations in Psychedelic Therapy (Psychedelic Science Review)

• As Plant-Medicine Churches Grow, Legal Questions Linger (Lucid News)

• This Psychedelic Theater Troupe Has Been Quietly Changing the World for Decades (DoubleBlind)

• Do Psychedelic Trips Actually Start In The Gut Instead Of The Brain? (Healing Maps)

• The Psychedelic Community Takes Itself Too Seriously (Psychedelic Alpha)

• Ethics in Psychedelic Therapy: The Promises and Pitfalls of Increased Suggestibility (Sam Woolfe)

• Do You Even Trip, Bro? On Psychedelic Masculinity (Psychedelic Spotlight)

• How Long Can the Psychedelic Renaissance Last? (Psychedelic Spotlight)

• The Legal Risks of Psychedelic Therapy and Coaching (EntheoNation)

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.